Clinical Trials List
Protocol NumberET743-OVA-301
Not yet recruiting
Phase III
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
張簡展照
Co-Principal Investigator
Principal Investigator
Chyong-Huey Lai
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
650 participants
